StockData
AnaptysBio, Inc logo

AnaptysBio, Inc (ANAB) stock

ANABNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 9/30
$49.24+2.63 (+5.64%)

Close on Oct 19, 2026Market cap $2.28BP/E –Yield –

AnaptysBio market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

AnaptysBio's market cap was $1.46B on Oct 19, 2026, against $682.17M a year earlier. Over the last 5 years it ranged from $250.52M to $1.96B, with a median of $456.37M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Oct 19, 2026$1.46B+64.2%
2025Dec 31, 2025$891.23M+231.8%
2024Dec 31, 2024$268.58M-29.2%
2023Dec 29, 2023$379.49M-35.2%
2022Dec 30, 2022$585.80M-7.9%
2021Dec 31, 2021$636.01M+62.3%
2020Dec 31, 2020$391.96M+33.5%
2019Dec 31, 2019$293.56M-74.2%
2018Dec 31, 2018$1.14B-17.3%
2017Dec 29, 2017$1.38B–

More AnaptysBio figures

See a number that looks wrong?